Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Eli Lilly and Company
Pfizer
Dana-Farber Cancer Institute
Pfizer
Tizona Therapeutics, Inc
Genentech, Inc.
Amgen
IDEAYA Biosciences
Novartis
M.D. Anderson Cancer Center
Eli Lilly and Company
Novartis
Amgen
Sairopa B.V.
Tempest Therapeutics
Valo Therapeutics Oy
Epkin
Bicara Therapeutics
Xencor, Inc.
Incyte Corporation
Toray Industries, Inc
Trishula Therapeutics, Inc.
DEKA Biosciences
Boehringer Ingelheim
Turnstone Biologics, Corp.
Merck Sharp & Dohme LLC
Carisma Therapeutics Inc
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Eli Lilly and Company
Astellas Pharma Inc
NGM Biopharmaceuticals, Inc
Adlai Nortye Biopharma Co., Ltd.
Pliant Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
Ikena Oncology
Stingthera, Inc.
Hefei TG ImmunoPharma Co., Ltd.
Corvus Pharmaceuticals, Inc.
Emory University
Fate Therapeutics
Oncorus, Inc.
Fate Therapeutics
Xencor, Inc.
NSABP Foundation Inc
University Hospital Heidelberg
Incyte Corporation